EichorEICHOR
Location: Fort Lauderdale Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Fort Lauderdale

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · Florida Kidney Physicians, LLC - Fort Lauderdale · Boehringer Ingelheim · NCT07355296
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
Phase 1/Phase 2 · 5055, South Florida CDTC Fort Lauderdale Clinical Research S · National Institute of Allergy and Infectious Diseases (NIAID · NCT02140255
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
Phase 2 · CAN Community Health Fort Lauderdale · Gilead Sciences · NCT07645287
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Florida Kidney Physicians, LLC - Fort Lauderdale · Boehringer Ingelheim · NCT07220083
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung C
Phase 3 · The Oncology Institute of Hope and Innovation - Fort Lauderd · Merck Sharp & Dohme LLC · NCT06623422
A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO
Phase 2 · Fort Lauderdale, Florida · EyeBiotech Ltd. · NCT07205887
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Particip
Phase 3 · The Oncology Institute of Hope and Innovation - Fort Lauderd · Bayer · NCT06452277
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
Phase 2 · Retina Group of Florida - Fort Lauderdale Retina Center · Boehringer Ingelheim · NCT06962839
ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and S
Phase N/A · Holy Cross Health Fort Lauderdale · Emory University · NCT07559903
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Phase 3 · Hoffmann-La Roche · NCT03683251
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus
Phase 2/Phase 3 · Helios Clinical Research - Fort Lauderdale · Bristol-Myers Squibb · NCT07063745
A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Sup
Phase 2 · FXM Clinical Research - Fort Lauderdale- Site Number : 84000 · Sanofi · NCT07225569
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Fort Lauderdale Heart and Rhythm · Stryker Instruments · NCT03072927
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Phase 2/Phase 3 · Retina Group of Florida (Site 070) · EyeBiotech Ltd. · NCT07440225
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
Phase 3 · Florida Kidney Physicians · Prokidney · NCT05099770
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adult
Phase 3 · CAN Community Health Fort Lauderdale · Gilead Sciences · NCT07682961
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure P
Phase 3 · Fort Lauderdale, FL Investigative Site 10114 · Colorado Prevention Center · NCT06008197
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Phase 3 · Retina Group of Florida - Fort Lauderdale · EyePoint Pharmaceuticals, Inc. · NCT07449923
Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Relat
Phase 3 · Retina Group of Florida - Fort Lauderdale · Ocular Therapeutix, Inc. · NCT07516132
Look up another city
Look up another condition